• About
  • AllayPalooza 2023
  • Partners
  • Cannabis Business Practicum
  • Contact Us
Allay Cannabis Compliance Consulting
  • Home
  • Cultivation
  • Manufacturing
  • Dispensary
  • Hemp
  • Psilocybin
  • Services
    • cGMP Certification
    • Organic Certification
  • News
    • Cultivation
    • Manufacturing
    • Dispensary
    • Hemp
    • Psilocybin
    • Company
Select Page
Allay on Cannabis Science and Technology: FDA Not Adopting Existing Regulations for the CBD Industry

Allay on Cannabis Science and Technology: FDA Not Adopting Existing Regulations for the CBD Industry

Mar 15, 2023 | Manufacturing

Allay on Cannabis Science and Technology: FDA Not Adopting Existing Regulations for the CBD Industry This is an excerpt from an article found on Skunk Magazine and technology FULL ARTICLE This blog is in response to the January 26th, 2023 announcement from the Food...
Allay on Cannabis Science and Technology: FDA Not Adopting Existing Regulations for the CBD Industry

Allay Consulting’s March Newsletter: USDA Cracking Down on Organic Fraud

Mar 8, 2023 | Manufacturing

Allay Consulting’s March Newsletter: USDA Cracking Down on Organic Fraud USDA Cracking Down on Organic Fraud Consumers want options, especially when purchasing products, and organic seems to be a popular selection. Organic items are widely available and can be...
Allay Consulting and The GMP Collective Combine Forces to Broaden Reach Across Cannabis, Hemp and Psychedelics

Allay Consulting and The GMP Collective Combine Forces to Broaden Reach Across Cannabis, Hemp and Psychedelics

Feb 28, 2023 | Company

Allay Consulting and The GMP Collective Combine Forces to Broaden Reach Across Cannabis, Hemp and Psychedelics Leading Regulatory Compliance Firms’ Partnership Expands Services for Manufacturers, Retailers and Healing Centers as State and Federal Policies Shift...
Allay Consulting’s February Newsletter: FDA Will Not Use Existing Regulations for the CBD Industry

Allay Consulting’s February Newsletter: FDA Will Not Use Existing Regulations for the CBD Industry

Feb 9, 2023 | Hemp, Manufacturing

Allay Consulting’s February Newsletter: FDA Will Not Use Existing Regulations for the CBD Industry FDA Will Not Use Existing Regulations for the CBD Industry The hemp industry has been in a bit of a pickle for several years: hemp derived cannabinoids are federally...
Allay Consulting January Newsletter: Unpacking Recent Cannabis Emerging Markets

Allay Consulting January Newsletter: Unpacking Recent Cannabis Emerging Markets

Jan 10, 2023 | Dispensary, Manufacturing

Unpacking Recent Cannabis Emerging Markets Voters have spoken – putting pen to paper, citizens throughout the US are supporting cannabis legalization. 2022 was a somewhat blooming year in normalizing cannabis in the United States. Several states legalized...
« Older Entries

Recent posts

  • Allay on Cannabis Science and Technology: FDA Not Adopting Existing Regulations for the CBD Industry
  • Allay Consulting’s March Newsletter: USDA Cracking Down on Organic Fraud
  • Allay Consulting and The GMP Collective Combine Forces to Broaden Reach Across Cannabis, Hemp and Psychedelics
  • Allay Consulting’s February Newsletter: FDA Will Not Use Existing Regulations for the CBD Industry
  • Allay Consulting January Newsletter: Unpacking Recent Cannabis Emerging Markets
  • Instagram
  • LinkedIn
© COPYRIGHT 2023 ALLAY CONSULTING | ABOUT | JOIN OUR NEWSLETTER